EPS for rest of 2014 is an $0.18 cent loss
EPS for 2015 is $1.16 loss
So the stock price of $6.31 today + $1.34 in losses is $7.65
Cash $5.60 + Revenue $1.87 = $7.47, However with losses coming it makes sense to subtract $1.34
You get a fair value of $6.13
Yet the stock today is higher than Cash + Revenue - 2014/2015 losses.
Please explain how ECYT is worth more than this formula of CASH + REVENUE - LOSSES?
That's a pretty fair metric for most companies in the short term.
Also, I think I just proved the bottom should be $6 unless we know that 2016 is also more losses
I'm glad you've convinced yourself, either you'll never buy the stock as a long or lose as a short. I think you'd be better crunching the numbers on a stock that wasn't in the Biotech sector.